Idexx Laboratories launches new BVDV RNA test

Idexx Laboratories has announced the launch of its new RealPCR BVDV RNA Test, a new means of diagnosing bovine viral diarrhoea virus (BVDV).

The new product utilises polymerase chain reaction (PCR) principles to detect multiple strains of the disease, including BVDV types 1 and 2, HoBi-like pestivirus – also known as BVDV type 3 – and border disease virus.

It is designed for optimal use in low-prevalence situations using pooled samples – for example, ear notches or serum/plasma – or to confirm results of other screening tests. It offers built-in quality controls and is supported by the IDEXX RealPCR Quality Control System.

Like other components of the company's RealPCR Modular System, it can be ordered separately from any of the other parts, eliminating the concept of traditional real-time PCR kits.

Olivier te Boekhorst, vice-president and general manager at Idexx, said: "Each component of the system has been optimised and validated for use together as a complete testing system."

Last month, the company published its financial results for the second quarter of 2014, during which it delivered nine percent year-on-year organic revenue growth.